These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6223558)

  • 1. Plasmin degradation of cross-linked fibrin.
    Marder VJ; Francis CW
    Ann N Y Acad Sci; 1983 Jun; 408():397-406. PubMed ID: 6223558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular model of plasmic degradation of crosslinked fibrin.
    Francis CW; Marder VJ
    Semin Thromb Hemost; 1982 Jan; 8(1):25-35. PubMed ID: 6460319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.
    Francis CW; Marder VJ; Barlow GH
    J Clin Invest; 1980 Nov; 66(5):1033-43. PubMed ID: 6448866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.
    Francis CW; Marder VJ; Martin SE
    Blood; 1980 Sep; 56(3):456-64. PubMed ID: 6447526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex.
    Olexa SA; Budzynski AZ
    Biochemistry; 1979 Mar; 18(6):991-5. PubMed ID: 154923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of fibrinogen and fibrin by plasmin and nonplasmin proteases in the chronic subdural hematoma: evaluation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot.
    Nomura S; Kashiwagi S; Ito H; Mimura Y; Nakamura K
    Electrophoresis; 1993 Dec; 14(12):1318-21. PubMed ID: 8137796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.
    Walker JB; Nesheim ME
    J Biol Chem; 1999 Feb; 274(8):5201-12. PubMed ID: 9988770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.
    Gaffney PJ; Lane DA; Brasher M
    Clin Sci Mol Med; 1975 Aug; 49(2):149-56. PubMed ID: 125178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.
    Olexa SA; Budzynski AZ; Marder VJ
    Biochim Biophys Acta; 1979 Jan; 576(1):39-50. PubMed ID: 153766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments.
    Weisel JW; Francis CW; Nagaswami C; Marder VJ
    J Biol Chem; 1993 Dec; 268(35):26618-24. PubMed ID: 7902838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
    Marder VJ; Budzynski AZ; Barlow GH
    Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis.
    Gogstad GO; Brosstad F
    Thromb Res; 1983 Jun; 30(5):441-8. PubMed ID: 6225217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of high molecular weight derivatives of plasmic digests of cross-linked human fibrin.
    Regañon E; Vila V; Aznar J
    Thromb Haemost; 1978 Oct; 40(2):368-76. PubMed ID: 153595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.